ID: ALA1778154

Max Phase: Preclinical

Molecular Formula: C39H73NO14

Molecular Weight: 780.01

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C[C@H](C)O)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@]1(C)O

Standard InChI:  InChI=1S/C39H73NO14/c1-14-27-39(11,48)32(44)22(5)29(42)19(2)16-37(9,47)34(54-36-30(43)26(15-21(4)50-36)40(12)18-20(3)41)23(6)31(24(7)35(46)52-27)53-28-17-38(10,49-13)33(45)25(8)51-28/h19-34,36,41-45,47-48H,14-18H2,1-13H3/t19-,20+,21-,22+,23+,24-,25+,26+,27-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39-/m1/s1

Standard InChI Key:  XKDBKVQGKLXZNJ-IPPRFSLISA-N

Associated Targets(non-human)

Motilin receptor 232 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 780.01Molecular Weight (Monoisotopic): 779.5031AlogP: 1.33#Rotatable Bonds: 9
Polar Surface Area: 217.30Molecular Species: BASEHBA: 15HBD: 7
#RO5 Violations: 3HBA (Lipinski): 15HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.45CX Basic pKa: 9.20CX LogP: 1.64CX LogD: -0.16
Aromatic Rings: 0Heavy Atoms: 54QED Weighted: 0.16Np Likeness Score: 1.62

References

1. Liu Y, Carreras CW, Claypool M, Myles DC, Shaw SJ..  (2011)  The role of the 4''-hydroxyl on motilin agonist potency in the 9-dihydroerythromycin series.,  21  (12): [PMID:21570844] [10.1016/j.bmcl.2011.04.078]

Source